Sustiva (Efavirenz) Macluumaadka Daroogada HIV

Isticmaalka, Tixgelinno, iyo Contraindications

Sustiva (efavirenz) waa daawo antiretrovoviral ah oo loo isticmaalo daaweynta HIV ee dadka waaweyn iyo carruurta.

Sustiva waxaa lagu qeexay sida non-nucleoside transcriptase inhibitor (NNRTI) sidoo kale waa qayb ka mid ah daawada loo isticmaalo daawada qiyaasta daawada loo yaqaan ' Atripla' (tenofovir + emtricitabine + efavirenz) oo badanaa loo isticmaalo daaweynta koowaad ee daweynta Maraykanka

Sustiva ayaa loo ansixiyay isticmaalka Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA) 21-kii Sebtembar, 1998.

Yurub iyo qaybo kale oo adduunka ka mid ah, daroogada ayaa lagu suuq-gareeyay magac ganacsi oo kala duwan, Stocrin.

Nidaamka Daroogada

Sustiva waxaa laga helaa kaniiniga 600mg. Kiniiniga jaalaha ah, kiniiniga qafiifka ah waa filim duuban oo daabacan "SUSTIVA" oo labada dhinac ah.

Sustiva waxaa sidoo kale laga heli karaa 200mg iyo 50mg oo ah foomka kaabsarka. Kaabayaasha 200mg waa dahab dahab ah, waxaa lagu daabacay "SUSTIVA" oo ku jirta jidhka kaabsaar ah iyo "200 mg" oo ku yaal daboolka. Kaabayaasha 50mg waxay leeyihiin dabool dahab ah oo lagu daabacay "SUSTIVA" iyo jir cad oo lagu daabacay "t0 mg."

Sustiva waa inaan waligaa loo isticmaalin sida monotherapyka, lakiin halkii lagu daro daawooyinka kale ee daawada antiretroviral .

Isugeynta

Dadka qaangaarka ah, qaado hal kiniin ah 600mg maalintii, si caadi ah ka hor wakhtiga hurdada iyo calool madhan. Faa'iido ahaan:

Carruurta ugu yaraan saddex sano jir ah iyo in ka badan 7.7 rodol (35kg), u qor sida soo socota:

Cudurka sustiva waa la liqaa oo dhan ama rusheeyaa. Sustiva ee qaabka kiniinka, dhanka kale, waa inaan waligaa la jajabin, sababtoo ah taasi waxay sababi kartaa daaweyn aan ku filneyn (ama marba xad dhaaf ah) carruurta.

Saameynada Caadiga ah

Waxyeellooyinka ugu badan ee la xiriira isticmaalka Sustiva (10% kiisaska ama ka yar) waa:

Calaamadaha badankoodu guud ahaan waa kuwo gaaban, inta badan waxay is-xallinayaan dhowr toddobaad gudahood illaa bil. Qaar ka mid ah saameynta nidaamyada dhexe ee dareemayaasha (dawakhaad, diirad saarid) waxaa lagu yarayn karaa Sustiva ka hor wakhtiga jiifka.

Sustiva-Associated Rashes

Daraasad lagu sameeyay kiliinikada, 26% bukaanada dhawaan soo gaadhay Sustiva waxay dareemeen heerar qafiif ah maqaarka, inkastoo intooda badani ay ahaayeen mid sahlan oo dhexdhexaad ah oo badanaa badanaaba waxay u muuqdaan labadii toddobaad ee hore ee bilowga.

Haddii aad furo finan yar kadib markaad bilowdo Sustiva, la xiriir dhakhtarkaaga ama bixiyaha xanaanada caafimaadka. Xaalad dhif ah (in ka yar 1% kiisaska), firiiricu wuxuu noqon karaa mid aad u daran, oo keenaya xummad iyo xummad, taasoo muujinaysa jiritaanka jirka ee loo yaqaan 'Stevens-Johnson syndrome', kaas oo u baahan in la joojiyo oo keliya daaweynta laakiin daaweyn dhakhso ah dareenka.

Dhammaan kiisaska kale, finanku waxay inta badan xalinayaan iyagoo aan joojin daaweyn.

Khilaafaadka

Sustiva waa inaan waligeed loo isticmaalin daawooyinka kale ee non-nucleoside transcriptase: Edurant (rilpivirine), Intelence (etravirine), Rescriptor (delavirdine), ama Viramune (nevirapine).

Bukaanka qaba dareen-celin hore u-qaadis Sustiva-oo ay ku jirto cirbadda Stevens-Johnson ( eeg xagga sare ) ama qarxinta maqaarka sunta ah - waa in aan lagu soo celinin daroogada ama qandaraaska Atripla, oo ah qiyaas daawo oo isku dhafan oo ay ku jiraan Sustiva.

Sustiva sidoo kale laguma talineynin marka lagu daro daawooyinka cagaarshow C (HCV) Victrelis (boceprevir) iyo Olysio (simeprevir) sababtoo ah luminta saameynta daaweynta ee labadan antibiraal HCV.

Tixgelinta Daaweynta

Sustiva waxaa lala xiriiriyay cilladaha uur-ku-jirka ee dhowr nooc oo xayawaan ah. In kastoo ay weli jirto muran ka taagan in Sustiva ay halis dhab ah u leedahay bini-aadamka, waxaa lagu talinayaa in Sustiva laga fogaado inta lagu jiro uurka, gaar ahaan saddexda bilood ee ugu horeeya. Hooyooyinka ayaa sidoo kale lagula talinayaa in aysan naas nuujin markaad qaadaneyso Sustiva.

Ilaha:

Maamulka Cuntada iyo Dawooyinka Maraykanka (FDA). "Package Approval Pack - Sustiva (efavirenz) 50mg, 100mg, 200mg capsules." Silver Spring, Maryland; la soo saaray 21-kii Sebtembar, 1998.